Asthma and Chronic Obstructive Pulmonary Disease (COPD) are the two major chronic respiratory diseases in Australia, with the incidence of asthma among the highest in the world, and COPD a major cause of death.
These disorders are a significant health and economic burden to the community. Researchers in the HMRI VIVA program are focused on understanding the cellular and molecular processes that are associated with the development and progression of respiratory diseases, such as asthma and COPD.
Chronic diseases of the airways including asthma are extremely common in Australia. In fact, the prevalence of asthma in Australia is among the highest in the world (Source – Global Asthma Report)
HMRI researcher Dr Matt Dun has revealed a more targeted way of treating T-cell acute lymphoblastic leukaemia (T-ALL), an aggressive cancer prevalent in children.